Red Light‐Triggered Anti‐Angiogenic and Photodynamic Combination Therapy of Age‐Related Macular Degeneration (Adv. Sci. 31/2023)

Red Light‐Activated Combination Therapy of Eye Diseases In article number 2301985, Xiaoling Liang, Weiping Wang, and co‐workers report a red‐light‐triggered intraocular drug release strategy to achieve combination treatment of wet age‐related macular degeneration. Intravenous administration of a pho...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Shuting, Cui, Kaixuan, Long, Kaiqi, Li, Jia, Fan, Ni, Lam, Wai‐Ching, Liang, Xiaoling, Wang, Weiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Inside Front Cover
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625050/
http://dx.doi.org/10.1002/advs.202370211
_version_ 1785131045262196736
author Xu, Shuting
Cui, Kaixuan
Long, Kaiqi
Li, Jia
Fan, Ni
Lam, Wai‐Ching
Liang, Xiaoling
Wang, Weiping
author_facet Xu, Shuting
Cui, Kaixuan
Long, Kaiqi
Li, Jia
Fan, Ni
Lam, Wai‐Ching
Liang, Xiaoling
Wang, Weiping
author_sort Xu, Shuting
collection PubMed
description Red Light‐Activated Combination Therapy of Eye Diseases In article number 2301985, Xiaoling Liang, Weiping Wang, and co‐workers report a red‐light‐triggered intraocular drug release strategy to achieve combination treatment of wet age‐related macular degeneration. Intravenous administration of a photoactivatable nanosystem followed by light irradiation to the diseased eye leads to intraocular release of an anti‐angiogenic agent, together with selective neo‐vessels occlusion by photodynamic therapy. This study provides a promising paradigm for minimally invasive administration of combination therapeutic agents for angiogenic eye diseases. [Image: see text]
format Online
Article
Text
id pubmed-10625050
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-106250502023-11-05 Red Light‐Triggered Anti‐Angiogenic and Photodynamic Combination Therapy of Age‐Related Macular Degeneration (Adv. Sci. 31/2023) Xu, Shuting Cui, Kaixuan Long, Kaiqi Li, Jia Fan, Ni Lam, Wai‐Ching Liang, Xiaoling Wang, Weiping Adv Sci (Weinh) Inside Front Cover Red Light‐Activated Combination Therapy of Eye Diseases In article number 2301985, Xiaoling Liang, Weiping Wang, and co‐workers report a red‐light‐triggered intraocular drug release strategy to achieve combination treatment of wet age‐related macular degeneration. Intravenous administration of a photoactivatable nanosystem followed by light irradiation to the diseased eye leads to intraocular release of an anti‐angiogenic agent, together with selective neo‐vessels occlusion by photodynamic therapy. This study provides a promising paradigm for minimally invasive administration of combination therapeutic agents for angiogenic eye diseases. [Image: see text] John Wiley and Sons Inc. 2023-11-04 /pmc/articles/PMC10625050/ http://dx.doi.org/10.1002/advs.202370211 Text en © 2023 Wiley‐VCH GmbH https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Inside Front Cover
Xu, Shuting
Cui, Kaixuan
Long, Kaiqi
Li, Jia
Fan, Ni
Lam, Wai‐Ching
Liang, Xiaoling
Wang, Weiping
Red Light‐Triggered Anti‐Angiogenic and Photodynamic Combination Therapy of Age‐Related Macular Degeneration (Adv. Sci. 31/2023)
title Red Light‐Triggered Anti‐Angiogenic and Photodynamic Combination Therapy of Age‐Related Macular Degeneration (Adv. Sci. 31/2023)
title_full Red Light‐Triggered Anti‐Angiogenic and Photodynamic Combination Therapy of Age‐Related Macular Degeneration (Adv. Sci. 31/2023)
title_fullStr Red Light‐Triggered Anti‐Angiogenic and Photodynamic Combination Therapy of Age‐Related Macular Degeneration (Adv. Sci. 31/2023)
title_full_unstemmed Red Light‐Triggered Anti‐Angiogenic and Photodynamic Combination Therapy of Age‐Related Macular Degeneration (Adv. Sci. 31/2023)
title_short Red Light‐Triggered Anti‐Angiogenic and Photodynamic Combination Therapy of Age‐Related Macular Degeneration (Adv. Sci. 31/2023)
title_sort red light‐triggered anti‐angiogenic and photodynamic combination therapy of age‐related macular degeneration (adv. sci. 31/2023)
topic Inside Front Cover
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625050/
http://dx.doi.org/10.1002/advs.202370211
work_keys_str_mv AT xushuting redlighttriggeredantiangiogenicandphotodynamiccombinationtherapyofagerelatedmaculardegenerationadvsci312023
AT cuikaixuan redlighttriggeredantiangiogenicandphotodynamiccombinationtherapyofagerelatedmaculardegenerationadvsci312023
AT longkaiqi redlighttriggeredantiangiogenicandphotodynamiccombinationtherapyofagerelatedmaculardegenerationadvsci312023
AT lijia redlighttriggeredantiangiogenicandphotodynamiccombinationtherapyofagerelatedmaculardegenerationadvsci312023
AT fanni redlighttriggeredantiangiogenicandphotodynamiccombinationtherapyofagerelatedmaculardegenerationadvsci312023
AT lamwaiching redlighttriggeredantiangiogenicandphotodynamiccombinationtherapyofagerelatedmaculardegenerationadvsci312023
AT liangxiaoling redlighttriggeredantiangiogenicandphotodynamiccombinationtherapyofagerelatedmaculardegenerationadvsci312023
AT wangweiping redlighttriggeredantiangiogenicandphotodynamiccombinationtherapyofagerelatedmaculardegenerationadvsci312023

Ejemplares similares